Subcostal TAP Block For Percutaneous Nephrolithotomy
Nephrolithiasis
About this trial
This is an interventional treatment trial for Nephrolithiasis focused on measuring percutaneous nephrolithotomy, subcostal transversus abdominis plane block, pain, paracetamol, tramadol, morphine, nephrolithiasis, lidocaine, bupivacaine
Eligibility Criteria
Inclusion Criteria:
- patients enrolled for percutaneous nephrolithotomy (PCNL) surgery
- ASA (American Society of Anesthesiologists) score I-III
Exclusion Criteria:
- patients with chronic pain
- patients on opioid or other analgesic drugs
- BMI (body mass index) higher than 40
- allergies for drugs used in the study
- chronic renal failure receiving dialysis
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Subcostal TAP group
Non- TAP group
Ultrasound guided Subcostal transversus abdominis plane block is performed after anesthesia induction and endotracheal intubation , to the side where kidney stone is. A composition of 10 ml Lidocaine %1 plus 10 ml physiologic saline solution plus 10 ml Bupivacaine %0,25 , total of 30 ml of local anesthetic mixture is administered into the area between internal oblique muscle fascia and transversus abdominis muscle fascia. After that, the patient is positioned to lithotomy position and the open-end catheter is inserted. After that the patient is turned to prone position and the percutaneous nephrolithotomy is performed. Tramadol 100 mg iv is administrated 20 minutes before the end of the surgery. Morphine patient controlled analgesia is planned for postoperative pain management.
Percutaneous nephrolithotomy is performed under general anesthesia. No regional analgesia is administered to this patients. Paracetamol 1000 mg/100ml; iv and Tramadol 100mg iv is administered 20 minutes before the end of the surgery for postoperative analgesia. Morphine patient controlled analgesia is planned for postoperative pain management.